TNF and Sepsis: These integrated findings illustrate that, among sepsis immunotherapies, only anti–TNF-α antibodies produced robust cytokine suppression and coagulation parameter improvement, whereas other targeted agents and IVIG preparations yielded more limited or inconsistent biomarker and microbiological responses.